MetaCap

Perspective Therapeutics Statistics

NYSE: CATXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.7538-0.0302 (-3.85%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Perspective Therapeutics by the numbers

Perspective Therapeutics has a market capitalization of $91.0 million based on 120.76M shares outstanding. With trailing EPS of $-1.25, Perspective Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 60.2% below its 50-day average and 77.5% below its 200-day average.

Average daily trading volume is 2.70M shares, or about $2.0 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CATX valuation vs. peer median

CATX compared with the median of 8 peer companies
MetricCATXPeer medianDifference
Market cap$91.03M$89.23M+2%
Avg. volume2.70M188.81K+1330%

Peer median across 8 companies: NTHI, CLLS, DERM, CPIX, RTSN, EQ, UPB, NRXP.

Valuation

Price and trading

Previous close
0.784
Open
0.7589
Day range
0.7407 – 0.79
52-week range
0.73 – 6.16
52-week change
-63.93%
Beta
—
Volume
1.39M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
91.03M
Forward Pe
-0.72
Eps
-1.25
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
6.16
Week52 Low
0.73
Avg Volume
2.70M
Shares Outstanding
120.76M
Ma50
1.89
Ma200
3.35
Earnings Date
Nov 9, 2026
Pct From52w High
-87.76%
Pct From52w Low
3.26%

Related